Spinal Inhibitory Dysfunction in Patients With Painful or Painless Diabetic Neuropathy.
Anne WorthingtonAlise KaltenieceMaryam FerdousiLuca D'OnofrioShaishav DhageShazli AzmiClare AdamsonShaheen HamdyRayaz A MalikNigel A CalcuttAndrew G MarshallPublished in: Diabetes care (2021)
We suggest that loss or impairment of HRDD may help to identify a subpopulation of patients with painful diabetic neuropathy mediated by impaired spinal inhibitory systems who may respond optimally to therapies that target spinal or supraspinal mechanisms. Enhanced RDD in patients without pain may reflect engagement of spinal pain-suppressing mechanisms.